1. Home
  2. CRBU vs NEN Comparison

CRBU vs NEN Comparison

Compare CRBU & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.79

Market Cap

203.9M

Sector

Health Care

ML Signal

HOLD

Logo New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

NEN

New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

N/A

Current Price

$65.00

Market Cap

239.3M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
CRBU
NEN
Founded
2011
1977
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
203.9M
239.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CRBU
NEN
Price
$1.79
$65.00
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$9.33
N/A
AVG Volume (30 Days)
5.0M
3.3K
Earning Date
11-12-2025
01-01-0001
Dividend Yield
N/A
7.34%
EPS Growth
N/A
N/A
EPS
N/A
3.33
Revenue
$9,295,000.00
$87,362,592.00
Revenue This Year
$8.06
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$20.22
Revenue Growth
N/A
7.63
52 Week Low
$0.66
$65.00
52 Week High
$3.54
$84.00

Technical Indicators

Market Signals
Indicator
CRBU
NEN
Relative Strength Index (RSI) 37.01 29.60
Support Level $1.72 $66.00
Resistance Level $1.97 $71.07
Average True Range (ATR) 0.15 0.95
MACD -0.01 -0.39
Stochastic Oscillator 11.21 0.00

Price Performance

Historical Comparison
CRBU
NEN

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.

Share on Social Networks: